Printer Friendly
The Free Library
4,444,672 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Browse Anti-HIV agents topic

Subtopics (44)

 

Articles

1-100 out of 100 article(s)
Title Author Type Date Words
CytoDyn Begins GMP Manufacturing of Its First-In-Class AIDS Drug. Jul 2, 2008 903
NanoViricides Anti-HIV Lead Drug Candidate Demonstrated Substantial Improvement in Survival Time in Animal Model. Jun 16, 2008 832
CytoDyn to Meet with Quest Clinical Research to Finalize Phase II Strategy for Novel AIDS Drug. Jun 5, 2008 443
Boehringer Ingelheim, Gilead Agree to AIDS Drug Price Freeze. Jun 3, 2008 715
Pharmaceuticals. May 31, 2008 84
'Shame on Merck': Drug Giant Blasted for Steep AIDS Drug Prices in Mexico in New US Print Ad Campaign by AHF. May 29, 2008 1124
Samaritan's Last-Ditch Salvage Therapy SP-01A Fighting "HIV Drug Resistance," Issued US Patent. May 20, 2008 436
AHF Supports Obama's Call for More AIDS Drugs for Poor Patients. Apr 15, 2008 747
Ziagen, Videx under safety review by FDA and EMEA. Apr 8, 2008 522
NanoViricides Commences HIV Drug Animal Trials. Apr 7, 2008 510
United States Rejects Key HIV/AIDS Drug Patents at PUBPAT Request. Jan 1, 2008 509
Roche Diagnostics, a World Leader in HIV Monitoring Tests, and ARK Diagnostics, Inc. Sign Letter of Intent to Commercialize ARK's HIV Drug Monitoring Products. Dec 6, 2007 476
Medivir: Initiation of a Phase IIa Clinical Trial with Investigational Hepatitis C Protease Inhibitor TMC435350. Nov 21, 2007 382
Gilead Announces 48-Week Data Evaluating Switching from Combivir(R) To Truvada(R) Among Virologically-Suppressed HIV Patients. Oct 29, 2007 2775
Long-Term Data Reinforce Safety and Efficacy Profile of Pfizer's New HIV Drug Selzentry(TM) (Maraviroc). Sep 18, 2007 843
Medivir: Preclinical Data Presented on New Hepatitis C Protease Inhibitor. Sep 10, 2007 181
Tests suggest new microbicide will have improved efficacy. Sep 1, 2007 607
Entry of New Drug Classes Redefining the HIV Market. Aug 8, 2007 228
Panacos Announces Five Presentations on its Antiviral Programs at International AIDS Society Conference. Clinical report Jul 25, 2007 988
ISENTRESS(TM) (raltegravir), an Investigational Oral HIV Integrase Inhibitor, in Combination Therapy Demonstrated HIV RNA Reduction Comparable to Efavirenz in Treatment-Naive HIV-Positive Patients. Clinical report Jul 24, 2007 1449
144-Week Data from Gilead's Study 934 Comparing Truvada(R) to Combivir(R) Both in Combination with Sustiva(R) Presented At International AIDS Society Meeting in Sydney. Jul 23, 2007 2612
Profectus BioSciences, Inc. Receives NIH Grant to Enhance Future Anti-HIV Therapies. Jul 18, 2007 342
Second Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint. Jun 25, 2007 1680
BRAZIL BREAKS HIV-DRUG PATENT AFTER FAILED NEGOTIATIONS WITH PHARMACEUTICAL GIANT MERCK. Jun 8, 2007 1136
Phase III Study Evaluating Gilead's Viread(R) for the Treatment of Chronic Hepatitis B Virus Meets Primary Endpoint. Jun 6, 2007 1741
Sustiva drug interactions. Jun 1, 2007 137
Clinton to lower cost of AIDS drugs. Brief article Jun 1, 2007 124
General public supports breaking drug patents to ensure access to HIV/AIDS drugs in poorer countries. Jun 1, 2007 407
Avexa Wins $4.3m Commercial Ready Grant for Anti-HIV Drug Discovery Program. May 30, 2007 449
Abbott taken to task for AIDS drug decision. Apr 27, 2007 448
GSK says tampering caused mislabeling of HIV medications. Brief article Apr 23, 2007 140
AIDS Drug Assistance Programs (ADAPs) Require National Solution. Apr 17, 2007 485
The next line of attack: the previous generation of anti-HIV drugs changed AIDS from an untreatable epidemic into a survivable disease. The next crop aims to get rid of the virus altogether. Kuhr, Fred Apr 10, 2007 840
Paths of glory: pathways to wellness, a holistic health center in Boston, mixes up a different HIV cocktail. Henderson, William Apr 10, 2007 708
AIDS medicine is rationed. Apr 1, 2007 219
Trimeris and Roche Amend Research Agreement Covering Next-Generation HIV Fusion Inhibitors. Mar 15, 2007 643
Sensitive Pediatric Pharmacology Assays for HIV Drugs Developed by Vitalea Science. Feb 19, 2007 533
Merck & Co., Inc., Again Reduces Price of STOCRIN (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic. Feb 14, 2007 1023
Basic research paving way to clinical care; Efforts earn doctor Diabetes Association award. Feb 12, 2007 926
Medivir: Clinical Phase I Trial with Hepatitis C Virus Protease Inhibitor Initiated. Feb 8, 2007 258
Cost of AIDS drug for poor attacked; Students call Abbott price `outrageous'. Jan 25, 2007 483
State claims half of those in need now on AIDS drugs. Bateman, Chris Brief article Jan 1, 2007 163
96-Week Data From Gilead's Study 934 Comparing Viread(R) and Emtriva(R) to Combivir(R) Both in Combination With Sustiva(R) Published in Journal of Acquired Immune Deficiency Syndrome. Dec 15, 2006 2834
African princess visits region for expired HIV/AIDS medications. Feliciano, Kimberly Dec 1, 2006 810
Sustiva: revised drug-interaction information. Nov 1, 2006 95
Landmark Five-Year Data on Gilead's Anti-HIV Drug Viread(R) Presented at 8th International Workshop on Adverse Drug Reactions and Lipodystrophy. Clinical report Sep 27, 2006 1667
Panacos to Present Data at 46th Annual ICAAC. Sep 20, 2006 484
Trimeris Extends Research Agreement with Roche Covering Next-Generation HIV Fusion Inhibitors; Research Term Extended for Additional 2 Years Through the End of 2008; TRI-1144 Advancing as the Lead Preclinical Candidate. Sep 7, 2006 527
An Investigational Oral HIV Integrase Inhibitor, MK-0518, in Combination Therapy Achieved Comparable HIV RNA Reduction to Efavirenz in Combination Therapy in Treatment-Naive, HIV-Infected Patients at 24 Weeks. Aug 17, 2006 1219
Panacos Presents Progress on HIV Fusion Inhibitor Program at International AIDS Conference. Aug 14, 2006 714
New Treatment Guidelines Support Use of FUZEON(R) to Achieve Undetectable HIV in Treatment-Experienced Patients. Aug 14, 2006 1298
An Investigational Oral HIV Integrase Inhibitor, MK-0518, in Combination Therapy Achieved Comparable HIV RNA Reduction to Efavirenz in Combination Therapy in Treatment-Naive, HIV-Infected Patients at 24 weeks. Aug 12, 2006 1220
New Data Show FUZEON(R) Continues to Provide Significant Immune System Benefits in Patients Despite Ongoing Viral Replication. Jun 26, 2006 1591
Heifer strategy fights HIV/AIDS with livestock. Turner, Lance Jun 26, 2006 154
U.S. FDA Approval of Boosted Protease Inhibitor Enables Potent New HIV Drug Combination with FUZEON(R). Jun 23, 2006 1531
Panacos Announces Study Elucidating PA-457's Mechanism of Action Published in Journal of Virology;Findings Corroborate Novel Target and Support Further Maturation Inhibitor Development. May 31, 2006 604
Feds Fund InforMedix in HIV Adherence Program; NIH Provides Funding to use the Med-eMonitor System to Monitor Medication and Care Plan Adherence in San Francisco HIV Patients. May 17, 2006 962
Incyte Begins Phase I Study of New HIV Drug in Healthy Volunteers. May 10, 2006 540
Merck Again Reduces Price of STOCRIN (efavirenz) for Patients in Least Developed Countries and Countries Hardest Hit by Epidemic; Double-Digit Reduction Helps Expand Access to HIV/AIDS Care and Treatment. Mar 7, 2006 1727
Wizzard Software Announces MedivoxRx Added to HealthCare Purchasing Partners International's 340 Prime Vendor Program for Low-Income Americans. Feb 9, 2006 815
Panacos to Present at BIO CEO & Investor Conference. Feb 7, 2006 317
The HIV trade-off: is "cost-effective" the right criterion for judging AIDS drugs? Batstone, David Feb 1, 2006 690
AIDS drugs released. Feb 1, 2006 125
A lifesaving cocktail. Romesburg, Don Brief Article Jan 17, 2006 158
Cocktail all in one: ten years after the introduction of the AIDS cocktail, many lives have been saved, but some problems still persist. Will a new one-a-day AIDS pill help? Kuhr, Fred Jan 17, 2006 820
Brazil, said Abbott Laboratories, a U.S. pharmaceutical agreed to cut the price of its Kaletra AIDS drug to US$0.63 from $1.17 per pill. Jan 1, 2006 39
Vertex to start Phase II trial for investigational Oral HCV protease inhibitor, FDA grants Fast Track designation. Dec 15, 2005 288
Samaritan CEO Provides Wall Street Transcript Update on Its Most Advanced Drug Discovery and Development Programs. Nov 17, 2005 283
Preliminary 24-Week Data Evaluating the Impact of Switching from Twice-Daily Combivir(R) to Once-Daily Truvada(R) in Patients with HIV Presented at 10th European AIDS Conference. Nov 17, 2005 1829
Samaritan Continues to Effectively Expand Valuable Patent Portfolio; Samaritan's Drug Development Pipeline Consists of 250 Possible Drug Candidates Based on Twenty-Six Patent Applications Worldwide. Nov 16, 2005 272
Academy Award Winner John Williams & Boston Pops Generously Give Concert March 2006 at Wynn Casino to Benefit Samaritan's Foundation. Nov 15, 2005 569
Simplicity is the Key to Survival in the HIV Market where Older Flagship Products such as Combivir are Now Under Threat. Nov 15, 2005 406
Defenders of property rights optimistic Brazil is backing away from United States AIDS drug patent threat. Nov 1, 2005 451
Failure of tenofovir + abacavir + 3TC combination; full report published, more insight. James, John S. Oct 1, 2005 430
Brazil said Abbott Laboratories, a U.S. pharmaceutical company, has agreed to cut the price of its AIDS drug Kaletra sold in the country. Brief Article Oct 1, 2005 54
Half the world's poor uses generic HIV drugs, U.S. urged to cooperate. Aug 22, 2005 209
HIV protease inhibitors vs. malaria. James, John S. Brief Article Jun 24, 2005 122
Therapeutic and diagnostic advances in the HAART era. Cheng, Ben Jun 22, 2005 2043
Clinton urges easier AIDS drugs policy. Jun 20, 2005 78
Welcome. Brief Article Apr 1, 2005 219
HIV and kidney function. Brief Article Apr 1, 2005 254
Hyperglycemia--another Viread + Videx risk. Brief Article Apr 1, 2005 105
Avoiding complications in HIV. Brief Article Apr 1, 2005 146
Doubts about hydroxyurea. Brief Article Apr 1, 2005 119
HIV in the brain. Apr 1, 2005 189
Hypertension risks. Brief Article Apr 1, 2005 171
Good news: the effects of HAART. Brief Article Apr 1, 2005 185
PA-457. Brief Article Apr 1, 2005 88
Tipranavir. Apr 1, 2005 91
"Compound X.". Brief Article Apr 1, 2005 15
One regimen, one pill, once a day. Brief Article Apr 1, 2005 85
New CDC guidelines to prevent HIV. Brief Article Apr 1, 2005 269
Methadone adjustment with Viramune. Brief Article Apr 1, 2005 93
Drugs for GI upset may interact with HIV protease inhibitors. Brief Article Apr 1, 2005 214
FDA approves generic version of Videx EC delayed release capsules. Brief Article Apr 1, 2005 96
Caution: combination of Viread, Videx, and either Sustiva or Viramune. Advertisement Apr 1, 2005 74
Sustiva warnings. Brief Article Apr 1, 2005 169
Liver toxicity warning. Advertisement Apr 1, 2005 85
Studies in Galveston. Apr 1, 2005 466
TCM & HIV/AIDS. Brief article Jun 1, 2004 78

Terms of use | Copyright © 2008 Farlex, Inc. | Feedback | For webmasters | Submit articles